JP2024088768A5 - - Google Patents

Download PDF

Info

Publication number
JP2024088768A5
JP2024088768A5 JP2024063204A JP2024063204A JP2024088768A5 JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5 JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5
Authority
JP
Japan
Prior art keywords
compound
cancer
inhibitors
alkyl
gpr55
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024063204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024088768A (ja
JP7868869B2 (ja
Filing date
Publication date
Priority claimed from JP2022519475A external-priority patent/JP7475731B2/ja
Application filed filed Critical
Publication of JP2024088768A publication Critical patent/JP2024088768A/ja
Publication of JP2024088768A5 publication Critical patent/JP2024088768A5/ja
Application granted granted Critical
Publication of JP7868869B2 publication Critical patent/JP7868869B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024063204A 2019-09-26 2024-04-10 カンナビノイドプロドラッグ化合物 Active JP7868869B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962906228P 2019-09-26 2019-09-26
US62/906,228 2019-09-26
JP2022519475A JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物
PCT/US2020/052829 WO2021062231A2 (en) 2019-09-26 2020-09-25 Cannabinoid prodrug compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022519475A Division JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物

Publications (3)

Publication Number Publication Date
JP2024088768A JP2024088768A (ja) 2024-07-02
JP2024088768A5 true JP2024088768A5 (enExample) 2024-10-28
JP7868869B2 JP7868869B2 (ja) 2026-06-02

Family

ID=75166839

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022519475A Active JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物
JP2024063204A Active JP7868869B2 (ja) 2019-09-26 2024-04-10 カンナビノイドプロドラッグ化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022519475A Active JP7475731B2 (ja) 2019-09-26 2020-09-25 カンナビノイドプロドラッグ化合物

Country Status (5)

Country Link
US (2) US11980602B2 (enExample)
EP (1) EP4034100A4 (enExample)
JP (2) JP7475731B2 (enExample)
CA (1) CA3152168A1 (enExample)
WO (1) WO2021062231A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116234812A (zh) * 2020-11-25 2023-06-06 成都百裕制药股份有限公司 大麻素类化合物的制备方法
CN115315418B (zh) * 2021-04-06 2023-03-21 山东绿叶制药有限公司 大麻二酚前药及其药物组合物和应用
CN116253671B (zh) * 2021-12-10 2025-07-04 德义制药有限公司 一种大麻二酚衍生物及其制备方法和应用
CA3257730A1 (en) * 2022-05-31 2023-12-07 Trait Biosciences, Inc. Compositions of water-soluble cannabinoid prodrugs and their synthesis processes
CN120531715B (zh) * 2025-05-28 2026-03-17 中国人民解放军军事科学院军事医学研究院 大麻二酚在寡肽转运体抑制剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008107879A1 (en) * 2007-03-05 2008-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel cannabidiol derivatives and their use as anti-inflammatory agents
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
JP6676176B2 (ja) * 2016-01-29 2020-04-08 ユニヴァーシティー オブ ミシシッピ 生物学的に活性なカンナビジオール類似体
CN109311838A (zh) * 2016-04-15 2019-02-05 蒂温诺特技术有限公司 大麻素前药的生物合成
CA3043653A1 (en) * 2016-11-15 2018-05-24 Jeffrey M. Korentur Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
US11610925B2 (en) 2019-06-06 2023-03-21 Applied Materials, Inc. Imaging system and method of creating composite images

Similar Documents

Publication Publication Date Title
JP2022542222A5 (enExample)
TWI915810B (zh) 抗體-藥物結合物之改良製造方法
JP2025041725A5 (enExample)
JPWO2020122034A5 (enExample)
JP2015508074A5 (enExample)
CN116457344B (zh) 低分子量蛋白质降解剂及其应用
JP2019501206A5 (enExample)
DK2678037T3 (en) Branched linker for protein pharmaceutical conjugates
JP2018016629A (ja) 固形腫瘍を治療するためのfap活性化プロテアソーム阻害剤
JP2017518304A5 (enExample)
JP2023527962A5 (enExample)
CN108863963B (zh) 作为pd-l1抑制剂的杂环类化合物
JP6957629B2 (ja) 非線状自壊性リンカーおよびそのコンジュゲート
ES2755101T3 (es) Nuevos compuestos y conjugados de criptoficina, su preparación y su uso terapéutico
JP2023545096A5 (enExample)
JP2006265245A5 (enExample)
JP2024509099A5 (enExample)
JP2018507197A5 (enExample)
CN113816990A (zh) 修饰的氨基酸及其在adc中的应用
RU2007135167A (ru) Комбинированная терапия с использованием анти-ctla4-антитела и индолинона для лечения рака
JP2018537975A5 (enExample)
RU2016130933A (ru) Сульфонамид-содержащие связывающие системы для лекарственных конъюгатов
JP2004529963A5 (enExample)
JP2016514103A5 (ja) 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体
JPWO2020027100A5 (enExample)